Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,125B 11.85B 10.61B 9.76B 8.84B 16.53B 16.84B 116B 46.72B 592B 44.46B 43.51B 1,866B P/E 2027 *
30.7x
P/E 2028 * 23.2x
Enterprise Value 1,094B 11.53B 10.32B 9.5B 8.6B 16.08B 16.38B 113B 45.46B 576B 43.26B 42.34B 1,816B EV / Sales 2027 *
3.12x
EV / Sales 2028 * 2.74x
Free-Float
69.73%
Yield 2027 *
0.55%
Yield 2028 * 0.62%
1 day+0.43%
1 week+7.11%
Current month+12.28%
1 month+10.27%
3 months+20.49%
6 months+3.20%
Current year+0.93%
1 week 13.6
Extreme 13.595
14.33
1 month 11.99
Extreme 11.99
14.33
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+7.11% - - 11.71B
+3.19%+8.48%+74.25%+153.03% 1,224B
-0.73%+2.09%+46.41%+87.64% 662B
+1.41%+3.40%+30.98%+112.26% 514B
+0.42%+2.88%+54.92%+69.67% 388B
+2.18%+1.55%+72.70%+45.42% 361B
+1.12%+3.80%+35.82%+59.72% 302B
+6.96%+7.55%+11.15%+37.89% 271B
+1.15%+4.19%+59.72%+78.16% 249B
+3.06%+8.58%+44.03%+122.76% 205B
Average +1.98%+2.59%+47.77%+85.17% 464.09B
Weighted average by Cap. +1.94%+3.04%+53.35%+100.42%

Financials

2027 *2028 *
Net sales 351B 3.7B 3.31B 3.05B 2.76B 5.16B 5.26B 36.35B 14.59B 185B 13.88B 13.59B 583B 393B 4.14B 3.71B 3.41B 3.09B 5.78B 5.89B 40.68B 16.33B 207B 15.54B 15.21B 652B
Net income 36.52B 385M 344M 317M 287M 537M 547M 3.78B 1.52B 19.21B 1.44B 1.41B 60.58B 49.15B 518M 464M 426M 386M 722M 736M 5.09B 2.04B 25.86B 1.94B 1.9B 81.54B
Net Debt -30.34B -320M -286M -263M -239M -446M -454M -3.14B -1.26B -15.96B -1.2B -1.17B -50.34B -49.26B -519M -465M -427M -387M -724M -737M -5.1B -2.05B -25.91B -1.95B -1.91B -81.71B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
31/10/26 US$14.17 +0.43% 1,826,378
29/10/26 US$14.11 -0.28% 2,112,545
28/10/26 US$14.15 +2.91% 4,468,802
27/10/26 US$13.75 0.00% 4,578,883
26/10/26 US$13.75 +4.09% 4,121,883
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,350.20INR
Average target price
1,358.95INR
Spread / Average Target
+0.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited